scispace - formally typeset
S

Suchira Bose

Researcher at Eli Lilly and Company

Publications -  19
Citations -  1170

Suchira Bose is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Tauopathy & Tau protein. The author has an hindex of 10, co-authored 14 publications receiving 992 citations.

Papers
More filters
Journal ArticleDOI

A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity

TL;DR: A novel in vivo model of tau propagation using human P301S tau transgenic mice infused unilaterally with brain extract containing tau aggregates is described and the rapid and robust propagation of t Tau pathology in this model will be valuable for both basic research and the drug discovery process.
Journal ArticleDOI

Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates

TL;DR: It is shown that seeding is conferred by aggregated Tau that enters cells through macropinocytosis and seeds the assembly of endogenous Tau into filaments, and conformational differences between native and synthetic Tau aggregates that may account for the higher seeding activity of native assembled Tau.
Journal ArticleDOI

Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau.

TL;DR: A range of filamentous tau aggregates are the major species that underlie the spreading of tau pathology in the P301S transgenic model, and it is shown that seed-competent tau species comprise small fibrils capable of seeding t Tau pathology in cell and animal models.